1995
DOI: 10.1016/s0140-6736(95)91864-7
|View full text |Cite
|
Sign up to set email alerts
|

Gut inflammation in children with cystic fibrosis on high-dose enzyme supplements

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

1996
1996
2016
2016

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 34 publications
(11 citation statements)
references
References 7 publications
0
11
0
Order By: Relevance
“… Intestinal alterations due to CFTR dysfunction may result in malnutrition with consistent respiratory muscle weakness and comprised innate lung defences [ 54 ], an impaired barrier function with consequent bacterial translocation to the lungs, and release of inflammatory mediators (cytokines such as interleukin (IL)-8, IL-1 and tissue necrosis factor (TNF)-a, immunoglobulins, lactoferrin, neutrophil elastase, and calprotectin [ 11 17 ]) into the systemic circulation, contributing to lung inflammation and impaired lung function. Inflammatory mediators in the lung (cytokines such as IL-8, IL-6, IL-1 and TNF-a, complement factor 5A, neutrophils, proteases (elastase), oxigen radicals, and leukotriene B4 [ 58 , 59 ]) are released into the systemic circulation and will reach the intestine or, alternatively, can be swallowed with sputum (together with lung bacteria) and enter the gastrointestinal tract.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“… Intestinal alterations due to CFTR dysfunction may result in malnutrition with consistent respiratory muscle weakness and comprised innate lung defences [ 54 ], an impaired barrier function with consequent bacterial translocation to the lungs, and release of inflammatory mediators (cytokines such as interleukin (IL)-8, IL-1 and tissue necrosis factor (TNF)-a, immunoglobulins, lactoferrin, neutrophil elastase, and calprotectin [ 11 17 ]) into the systemic circulation, contributing to lung inflammation and impaired lung function. Inflammatory mediators in the lung (cytokines such as IL-8, IL-6, IL-1 and TNF-a, complement factor 5A, neutrophils, proteases (elastase), oxigen radicals, and leukotriene B4 [ 58 , 59 ]) are released into the systemic circulation and will reach the intestine or, alternatively, can be swallowed with sputum (together with lung bacteria) and enter the gastrointestinal tract.…”
Section: Discussionmentioning
confidence: 99%
“…Evidence for intestinal inflammation in CF has been found in both human and animal studies [ 5 , 11 , 12 , 13 , 14 , 15 , 16 ]. Raised levels of cytokines (TNF-α), interleukins (IL-1β, IL-8), immunoglobulins (IgM, IgG), neutrophil elastase and calprotectin were demonstrated in faeces and whole gut lavage of CF patients [ 5 , 11 , 12 , 13 , 16 , 17 ]. Also increased mononuclear cell infiltration of the lamina propria has been shown in duodenal biopsies [ 15 ].…”
Section: Introductionmentioning
confidence: 99%
“…An ulcerative ileitis “Crohn-like”, as a result of the chronic pancreatic enzymes taking, has been described in the literature (Thomson and Tam 1994 ; Croft et al 1995 ; Smyth et al 1994 ; FitzSimmons et al 1997 ). According to the patient's medical history, our pathologist suggested it as a possible differential diagnosis, since in the specimen, apart from strictures and submucosal fibrosis with dense inflammatory cells, there were no granulomas, which are instead a feature of the CD.…”
Section: Discussionmentioning
confidence: 99%
“…The technique for intestinal anastomoses in CD is still controversial, and, to date, there is no evidence of outcome difference between hand-sewn and stapled anastomosis (Scarpa et al 2003 ). A temporary end-ileostomy or a diverting loop-ileostomy proximal to the anastomosis, can be considered in CD, especially in case of peritonitis with hemodynamic instability and when the patient’s general conditions and nutritional status are extremely poor (Ikeuchi and Yamamura 2002 ; Nordentoft et al 2000 ; Kesici et al 2011 ; Collet e Silva et al 2000 ; Neudecker et al 2002 ; Agresta et al 2012 ; O’Sullivan et al 1996 Apr; Favuzza et al 2009 ; Karoui et al 2009 ; Myers et al 2008 ; Thomson and Tam 1994 ; Croft et al 1995 ; Smyth et al 1994 ; FitzSimmons et al 1997 ; Greenstein et al 1985 , 1987 ; Abascal et al 1982 ; Parray et al 2011 ).…”
Section: Discussionmentioning
confidence: 99%
“…UC “Crohn-like”, coming from a chronic pancreatic enzyme taking, has been also described in the literature [ 26 , 37 , 38 ].…”
Section: Conditions Related To Ileitismentioning
confidence: 99%